Beth Israel Medical Center Study Identifies Possible Biomarker for Parkinson’s Disease

free biotech news

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Although Parkinson’s disease is the second most prevalent neurodegenerative disorder in the U.S., there are no standard clinical tests available to identify this widespread condition. As a result, Parkinson’s disease often goes unrecognized until late in its progression, when the brain’s affected neurons have already been destroyed and telltale motor symptoms such as tremor and rigidity have already appeared.

Hey, check out all the engineering jobs. Post your resume today!

MORE ON THIS TOPIC